Dulla Naveen Kumar

11PUBLICATIONS
22CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical bacteriologyGene and molecular therapyPowder and particle technologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 30, 2026
Folic Acid-Conjugated Solid Lipid Nanoparticles for Ratiometric Combination Delivery of Docetaxel and Erlotinib in Triple-Negative Breast Cancer Therapy.

|Jul 27, 2024
Combinatorial Delivery of Docetaxel- and Erlotinib-Loaded Functionalized Nanostructured Lipid Carriers for the Treatment of Triple-Negative Breast Cancer Using Quality-by-Design Approach.

Aiswarya Chaudhuri, Dulla Naveen Kumar, Saurabh Kumar Srivastava

|Jul 29, 2023
A Bacteriophage Microgel Effectively Treats the Multidrug-Resistant Acinetobacter baumannii Bacterial Infections in Burn Wounds.

Deepa Dehari, Aiswarya Chaudhuri, Dulla Naveen Kumar

|Jul 28, 2023
Quality-by-design-based development of ultradeformable nanovesicular transgelosome of standardized Piper longum extract for melanoma.

Debadatta Mohapatra, Dulla Naveen Kumar, Singh Shreya

|Jun 09, 2023
Quality by design-based development and optimization of fourth-generation ternary solid dispersion of standardized Piper longum extract for melanoma therapy.

Debadatta Mohapatra, Dulla Naveen Kumar, Singh Shreya

|May 13, 2023
Endorsement of TNBC Biomarkers in Precision Therapy by Nanotechnology.

Aiswarya Chaudhuri, Dulla Naveen Kumar, Deepa Dehari

Pageof 2

Frequent Collaborators

10 joint publications

Ashish Kumar Agrawal

9 joint publications

Aiswarya Chaudhuri

4 joint publications

Dinesh Kumar

2 joint publications

Singh Shreya